Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger Sequencing), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger Sequencing), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Microbiome Sequencing Services Market Growth & Trends

The global microbiome sequencing services market size is projected to reach USD 3.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.9% from 2023 to 2030, as a result of rising investment and an increase in genomic research globally. For instance, in October 2022, Danish microbiome research comp1any, Clinical Microbiomics announced that venture capital firm Seventure Partners had invested €10 million ($9.7 million) in the company. The funds will be used by Clinical Microbiomics to advance the systems biology and microbiome profiling platforms, as well as to broaden the scope of their service offerings for multi-omics data integration and extend their reach internationally, starting with the US. Due to a large number of genomic initiatives for research and development, the market for microbiome sequencing services is growing.

With growing evidence that microbiomes have a significant effect on human health, the research on microbiome sequencing has advanced considerably in recent years. Studies investigating the variety of microbes that exist on and inside human bodies are now possible easily since there have been major improvements in sequencing technologies and significant declines in the costs of services. Furthermore, growing research on how the human body's microbiome influences certain aspects of human physiology provides enormous potential for the development of novel treatments and preventative measures for a wide range of diseases including cancer, mental health disorders, autoimmune conditions, and infectious diseases. This growing research on the microbiome is expected to drive the demand for microbiome sequencing services.

The COVID-19 pandemic has had positive effects on the market for microbiome sequencing services. Microbiome sequencing is mainly employed in the fields of infectious disease and cancer. The existence of the virus and the host's reaction to COVID-19 may be determined through RNA sequencing. Therefore, one of the key factors supporting its development in 2020 and beyond was the increasing adoption of microbiome sequencing tools during the COVID-19 pandemic.

Moreover,the government's partnerships with industry participants for extensive virus research also fueled the pandemic's high demand for microbiome sequencing. For instance, the UK established a genome sequencing partnership in March 2020 to facilitate rapid, comprehensive, and exhaustive sequencing analysis of samples from patients who tested positive for COVID-19. The network seeks to sequence every positive patient sample for the virus. Oxford Nanopore is pleased to assist the teams working on this initiative in the UK

Microbiome Sequencing Services Market Report Highlights

• The sequencing by synthesis segment held the largest share of 57.5% in 2022 and is expected to expand at a lucrative CAGR during the forecast period. This is a result of the sequencing by synthesis method's highly parallel nature, which enables the simultaneous sequencing of millions of amplicons, which has greatly increased interest in the study of bacterial communities
• By application, the gastrointestinal disorders segment accounted for the largest share of 54.0% in the market in 2022. This can be attributed to the high incidences of gastrointestinal disorders and growing awareness related to the gut microflora and the use of probiotics
• By end-user, the academic research institutes segment held the largest share of 43.3% in 2022. The widespread application of microbiome sequencing services for protein, as well as small molecule analysis in research institutions and academics, contributes to the segment's high market share
• North America held the largest market share of 47.85% in 2022. The high regional market share is largely due to the rise in the usage of extremely sophisticated techniques and systems in microbiome sequencing services and the technological developments made in genomic research studies. Furthermore, the market in North America is expected to develop more rapidly due to the increase in the adoption of technologically advanced methods and platforms in the microbiome sequencing services and advances in technology made in genomic research studies

Please note The report will be delivered in 3-8 business days upon order notification.